Skip to content

Total 17-Hydroxyandrostenedione and Androstenedione Ratio (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test measures the ratio of two hormones involved in hormone balance, often checked in conditions affecting adrenal or gonadal function.

Quick summary

["Helps assess adrenal or reproductive hormone production and potential imbalances."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
53337-2
Short code
17OHCS+Androst/Cortis DBS-sRto
Synonyms
17OHCS+Androst/Cortis DBS-sRto
Category
hormone
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test evaluates two related steroid hormones: **17-hydroxyandrostenedione** and **androstenedione**. These compounds are precursors to sex hormones and play roles in metabolism, puberty, and reproductive health. The ratio helps identify whether production is elevated or suppressed, which can signal underlying endocrine disorders.

Why It’s Ordered

Your doctor may recommend this test if you have symptoms like irregular periods, low libido, excessive hair growth, or signs of hormonal imbalances. It’s also used in evaluating conditions such as congenital adrenal hyperplasia (CAH), polycystic ovary syndrome (PCOS), or adrenal tumors.

Sample Collection and Preparation

A blood sample is drawn from a vein, typically in the arm. The sample is processed into either serum (after clotting) or plasma (using an anticoagulant). Results are based on the concentration ratio of the two hormones measured in the specimen.

What to Expect Before the Test

No special preparation is usually needed, but avoid alcohol or certain medications (like steroids) for 24 hours before testing, as they may affect hormone levels.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Abnormal ratios may indicate conditions like **Congenital Adrenal Hyperplasia (CAH)**, where the adrenal glands produce excessive hormones early in life, or **adrenal insufficiency**, where hormone production is too low. In women, elevated ratios may relate to PCOS or androgen excess, while low ratios could suggest pituitary or gonadal dysfunction. Always discuss results with your healthcare provider.

Short name

17OHCS/Androstenedione Ratio

Frequently asked questions

When might I need this test?
This test is typically ordered if you have symptoms like hormonal imbalances (e.g., irregular periods, acne, or excessive body hair) or if your doctor suspects conditions like CAH, PCOS, or adrenal tumors.
How long will I wait for results?
Results are usually available within 1–3 business days, depending on lab processing times. Your doctor will explain what the ratio means in the context of your health.
Can I take anything to lower or raise hormone levels before testing?
Avoid alcohol, certain medications (like steroids), and extreme stress for 24 hours before testing. Follow your doctor’s specific instructions if you’re on ongoing hormone treatments.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy